查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1714730

肉毒桿菌毒素市场按类型、形式、给药方式、分销管道、应用和最终用户划分－2025 年至 2030 年全球预测

Botulinum Toxins Market by Type, Form, Mode of Administration, Distribution Channel, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

肉毒桿菌毒素市场规模预计在 2024 年达到 74.8 亿美元，在 2025 年达到 81.2 亿美元，在 2030 年达到 124.1 亿美元，复合年增长率为 8.81%。

主要市场统计数据
基准年2024年 74.8亿美元
预计2025年 81.2亿美元
预测年份 2030 124.1亿美元
复合年增长率（%） 8.81%

肉毒桿菌毒素市场已成为一个充满活力的行业，对化妆品和治疗行业都有广泛的影响。近年来，由于消费者偏好的不断变化、医疗技术的进步以及对微创手术的需求不断增加，该行业经历了前所未有的增长。本介绍性概述概述了市场的现状、其随时间的演变以及推动其发展的根本因素，为全面研究奠定了基调。市场受到大量研发投资的影响，并产生了创新的配方和交付系统。随着医疗保健提供者和美容从业者寻求有效的解决方案，肉毒桿菌不仅在临床治疗通讯协定中确立了地位，而且还彻底改变了脸部美学和慢性病治疗方法。在此背景下，了解产品类型、管理方法和应用领域的细微差别至关重要。以下部分将深入探讨这些因素，并提供细分、区域成长、主要企业、可行见解和策略建议的详细分类，以揭示肉毒桿菌毒素市场的内部动态和成长驱动因素。读者将深入了解影响市场趋势的变革性变化，同时考虑既定的做法和新兴的机会，以利用这个快速发展的利基市场。

改变肉毒桿菌市场

近年来，发生了一些变革，重新定义了肉毒桿菌市场格局。技术的进步，加上创新产品开发的激增，正在推动产品配方和交付方式的重大变化。科学研究和临床实践的融合推动了传统治疗通讯协定朝向更复杂的标靶治疗发展。该公司正在利用生物技术的进步来设计具有更高功效和安全性的配方，同时解决剂量准确性和患者定制等复杂挑战。世界各地的监管机构正在适应这些技术进步，以确保标准跟上快速发展的步伐。这些变化有助于扩大化妆品以外的治疗应用，为解决胃肠道疾病、肌肉痉挛、疼痛管理和其他复杂疾病的更广泛的医疗用途铺平了道路。人们也重新关注数位和线上零售管道，以简化供应链并提高最先进治疗的可及性。此外，强大的调查方法和临床专业知识的无缝整合创造了一个不断改善患者治疗结果和治疗成功率的环境，为疗效和安全性树立了新的标竿。

细分洞察推动市场动态

深入研究市场区隔可以揭示支持肉毒桿菌毒素产业成长和发展方向的关键见解。首先，按类型检查市场，区分 A 型和 B 型肉毒桿菌毒素，使相关人员能够辨别应用和整体性能的细微差别。除此之外，基于形式的分析强调了从传统粉末配方到更先进的液体配方的演变，强调精确性和易于管理。在评估给药方法方面，该行业已从传统的肌肉注射扩展到更复杂的皮内注射，反映出对实现更好临床结果的信心增强。该市场还根据分销管道进行评估，线下零售方式和快速成长的线上平台的结合凸显了数位创新在进入全球市场中的关键作用。前者探索脸部美学、多汗症和非手术拉皮，而后者涵盖胃肠道疾病、肌肉痉挛和麻痹以及疼痛管理的治疗通讯协定。这种整体方法透过考虑皮肤科诊所、医院和诊所、医疗水疗中心以及研究和学术机构等最终用户而得到丰富，每个机构都提供独特的见解，支持对市场格局的细緻了解。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球对非侵入性美容和整形手术的需求不断增长
      • 年轻人对美容益处的认识日益增强
      • 扩大肉毒桿菌毒素在医疗保健领域的治疗应用
    • 限制因素
      • 严格的法规结构和安全问题影响市场成长
    • 机会
      • 负担得起的美容治疗费用推动全球医疗旅游成长
      • 肉毒桿菌配方和创新传递技术的进展
    • 任务
      • 肉毒桿菌治疗费用高且报销有限
  • 市场区隔分析
    • 类型：A 型肉毒桿菌毒素因其治疗症状的有效性而越来越受欢迎。
    • 形式：液体形式的肉毒桿菌毒素越来越受到人们的青睐，可以快速有效地给药。
    • 给药方法：在皮肤科和美容手术中越来越多地使用皮内给药
    • 分销管道：消费者越来越多地偏好线下零售，寻求面对面的咨询和熟练专家的即时评估
    • 应用：扩大肉毒桿菌毒素在脸部轮廓改善的应用
    • 最终使用者：肉毒桿菌毒素在皮肤病诊所中越来越多地被使用来减少皱纹。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 肉毒桿菌毒素市场（按类型）

  • A型肉毒桿菌毒素
  • B型肉毒桿菌

7. 肉毒桿菌毒素市场（依形式）

  • 液体
  • 粉末

8. 肉毒桿菌毒素市场（依给药方式）

  • 皮内
  • 肌肉注射

9. 肉毒桿菌毒素市场（按分销管道）

  • 线下零售
  • 网路零售

第 10 章肉毒桿菌毒素市场（按应用）

  • 美学应用
    • 脸部美学
    • 多汗症
    • 非手术拉皮
  • 医疗用途
    • 胃肠道疾病
    • 肌肉痉挛与瘫痪
    • 疼痛管理

第 11 章 肉毒桿菌毒素市场（依最终用户）

  • 皮肤科诊所
  • 医院和诊所
  • 医疗水疗中心
  • 研究和学术机构

12. 美洲肉毒桿菌毒素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太地区肉毒桿菌毒素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

14. 欧洲、中东和非洲肉毒桿菌市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • AbbVie Inc.
  • Ajinomoto Bio-Pharma Services
  • ATGC Co.,Ltd.
  • Bioplus Co., Ltd.
  • Croma-Pharma GmbH
  • Daewoong Pharmaceuticals Co.Ltd.
  • Eirion Therapeutics, Inc.
  • Eisai Co., Ltd
  • Evolus, Inc.
  • Galderma SA
  • Gufic Biosciences Ltd.
  • HUGEL, Inc.
  • Hugh Source International Ltd.
  • Ipsen Pharma
  • Lanzhou Institute of Biological Products Co. Ltd.
  • Medytox Co., Ltd.
  • Merz Pharma GmbH & Co.KGaA
  • Object Pharma, Inc.
  • PharmaResearch Co. Ltd
  • Revance Therapeutics, Inc.
  • Shanghai Fosun Pharmaceutical（Group）Co., Ltd.
  • Supernus Pharmaceuticals, Inc.
  • Taj Pharmaceuticals
Product Code: MRR-4330CC794BD1

The Botulinum Toxins Market was valued at USD 7.48 billion in 2024 and is projected to grow to USD 8.12 billion in 2025, with a CAGR of 8.81%, reaching USD 12.41 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 7.48 billion
Estimated Year [2025] USD 8.12 billion
Forecast Year [2030] USD 12.41 billion
CAGR (%) 8.81%

The botulinum toxins market has emerged as a dynamic arena with far-reaching implications across both aesthetic and therapeutic landscapes. In recent years, the industry has witnessed unprecedented growth, driven by evolving consumer preferences, advancements in medical technology, and the increasing demand for minimally invasive procedures. This introductory overview sets the tone for a comprehensive exploration by outlining the market's current state, its evolution over time, and the fundamental factors steering its progression. The market has been shaped by significant investments in research and development, which have resulted in innovative formulations and delivery systems. As healthcare providers and cosmetic practitioners seek effective solutions, botulinum toxins have not only cemented their place in clinical treatment protocols but have also revolutionized approaches to facial aesthetics and chronic disorder treatments. In this context, understanding the nuances of product types, modes of administration, and application domains is indispensable. The following sections delve into these elements, providing a detailed breakdown of segmentation, regional growth, key players, actionable insights, and strategic recommendations that unmarry the internal dynamics and growth drivers of the botulinum toxins market. Readers will gain insights into the transformative shifts influencing market trends while considering both established practices and emerging opportunities to harness this rapidly evolving niche.

Transformative Shifts in the Market Landscape

Recent years have witnessed transformative shifts that have redefined the botulinum toxins market landscape. Technological advancements, coupled with a surge in innovative product development, have resulted in significant changes in product formulations and delivery methods. The convergence of scientific research and clinical practice has propelled the evolution from traditional treatment protocols to more sophisticated, targeted therapies. Companies are leveraging advances in biotechnology to design formulations that offer improved efficacy and safety profiles, while also addressing complexities such as dosage precision and patient customization. Regulatory bodies around the globe are adapting to these innovations, ensuring that standards keep pace with rapid progress. These changes have been instrumental in expanding therapeutic applications beyond aesthetics, paving the way for broader medical applications that address gastrointestinal disorders, muscle spasms, pain management, and other complex conditions. A renewed focus on digital and online retail channels has also emerged, striving to streamline the supply chain and enhance accessibility to state-of-the-art treatments. Furthermore, the seamless integration of robust research methodologies with clinical expertise has fostered an environment where patient outcomes and treatment success rates are continually improved, setting new benchmarks for both efficacy and safety.

Segmentation Insights Driving Market Dynamics

The deep dive into market segmentation reveals critical insights that underpin the growth and direction of the botulinum toxins industry. By examining the market through varied lenses-first by type, where research distinguishes between Botulinum Toxin Type A and Botulinum Toxin Type B-stakeholders can discern subtle differences in application and overall performance. Coupled with this, analysis based on form highlights the evolution from traditional powdered variants to more advanced liquid formulations that focus on precision and ease of administration. In assessing the mode of administration, the industry has expanded from conventional intramuscular techniques to more refined intradermal injections, reflecting increased confidence in achieving better clinical outcomes. The market is also evaluated through the perspective of distribution channels, where a blend of offline retail methods and burgeoning online platforms underscores the critical role of digital innovation in accessing global markets. Further segmentation into application-specific domains distinguishes between aesthetic and medical uses; the former investigates facial aesthetics, hyperhidrosis, and non-surgical facelifts, while the latter encompasses treatment protocols for gastrointestinal disorders, muscle spasms and paralysis, and pain management. This comprehensive approach is enriched by considering the end user, which includes dermatology clinics, hospitals and clinics, medical spas, and research and academic institutes, each contributing distinctive insights that support a nuanced understanding of market conditions.

Based on Type, market is studied across Botulinum Toxin Type A and Botulinum Toxin Type B.

Based on Form, market is studied across Liquid and Powder.

Based on Mode of Administration, market is studied across Intradermal and Intramuscular.

Based on Distribution Channel, market is studied across Offline Retail and Online Retail.

Based on Application, market is studied across Aesthetic Applications and Medical Applications. The Aesthetic Applications is further studied across Facial Aesthetics, Hyperhidrosis, and Non-Surgical Facelifts. The Medical Applications is further studied across Gastrointestinal Disorders, Muscle Spasms & Paralysis, and Pain Management.

Based on End User, market is studied across Dermatology Clinics, Hospitals & Clinics, Medical Spas, and Research & Academic Institutes.

Regional Dynamics Shaping Market Expansion

The regional landscape of the botulinum toxins market offers a window into the diverse factors driving growth in different parts of the world. In the Americas, robust healthcare infrastructures and high disposable incomes have created an environment conducive to both elective aesthetic procedures and essential therapeutic treatments. This region's emphasis on technological innovation continues to propel demand for advanced formulations and personalized treatment options. Meanwhile, the synergy of regulatory advancements and evolving consumer preferences in Europe, the Middle East, and Africa cannot be understated. Here, a balanced blend of traditional practices and modern medical interventions is driving growth, with regulatory frameworks that encourage both research and the introduction of novel products. Across Asia-Pacific, rapid urbanization, increased healthcare awareness, and a growing middle class are catalyzing market expansion. The region's dynamic pharmaceutical landscape is marked by both domestic innovation and substantial foreign investment, fostering competitive pricing and diverse product portfolios. This regional overview highlights how distinct economic, cultural, and regulatory factors contribute to localized market behavior while reinforcing the global demand for botulinum toxins across multiple applications.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Industry Leaders and Key Company Profiles

The competitive landscape of the botulinum toxins market is enriched by the presence of several established companies recognized for their commitment to research, innovation, and quality. Key players such as AbbVie Inc. and Ajinomoto Bio-Pharma Services have successfully navigated the market by continuously advancing product development strategies. Other major organizations, including ATGC Co., Ltd. and Bioplus Co., Ltd., have carved out niche segments within both aesthetic and medical applications by aligning their operations with cutting-edge technologies and stringent quality standards. Companies like Croma-Pharma GmbH and Daewoong Pharmaceuticals Co. Ltd. have steadily expanded their global footprints by combining effective distribution strategies with deep clinical expertise. In parallel, firms such as Eirion Therapeutics, Inc. and Eisai Co., Ltd. have bolstered their research programs, reinforcing the scientific underpinnings of the market. Organizations including Evolus, Inc., Galderma SA, and Gufic Biosciences Ltd. have also garnered attention for their pioneering formulations and targeted therapies. The landscape is further enhanced by entities like HUGEL, Inc. along with Hugh Source International Ltd., Ipsen Pharma, and the Lanzhou Institute of Biological Products Co. Ltd., each contributing to a diverse array of applications. Esteemed companies such as Medytox Co., Ltd. and Merz Pharma GmbH & Co. KGaA, along with Object Pharma, Inc., PharmaResearch Co. Ltd, and Revance Therapeutics, Inc., continue to drive market momentum with innovative therapies. The robust presence of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Supernus Pharmaceuticals, Inc., and Taj Pharmaceuticals underscores the commitment across the board to quality, efficacy, and market adaptation in line with evolving global trends.

The report delves into recent significant developments in the Botulinum Toxins Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Ajinomoto Bio-Pharma Services, ATGC Co.,Ltd., Bioplus Co., Ltd., Croma-Pharma GmbH, Daewoong Pharmaceuticals Co.Ltd., Eirion Therapeutics, Inc., Eisai Co., Ltd, Evolus, Inc., Galderma SA, Gufic Biosciences Ltd., HUGEL, Inc., Hugh Source International Ltd., Ipsen Pharma, Lanzhou Institute of Biological Products Co. Ltd., Medytox Co., Ltd., Merz Pharma GmbH & Co.KGaA, Object Pharma, Inc., PharmaResearch Co. Ltd, Revance Therapeutics, Inc., Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Supernus Pharmaceuticals, Inc., and Taj Pharmaceuticals. Actionable Recommendations for Industry Leaders

For industry leaders navigating the dynamic botulinum toxins market, several actionable recommendations can facilitate both short-term gains and long-term sustainable growth. It is imperative to prioritize investments in research and development to drive continuous innovation, especially in refining product formulations and administration methods. Embracing technological advances and incorporating digital tools can enhance precision in clinical applications, address diverse patient needs, and streamline operations. Leaders should also consider strategic partnerships, both locally and internationally, to expand distribution networks and tap into emerging markets. Building robust collaborations with regulatory bodies and academic institutions can further accelerate the integration of cutting-edge research into product offerings. Moreover, focusing on customer-centric strategies that emphasize safety, efficacy, and personalized treatment outcomes is critical. Investment in market intelligence and continuous competitor analysis can help anticipate competitive moves and adjust product strategies accordingly. Organizations must also adopt agile methodologies to stay ahead of evolving regulatory trends and market disruptions. By adopting these strategic imperatives, industry leaders are well-positioned to harness opportunities, mitigate risks, and maintain a competitive edge in a rapidly evolving healthcare landscape.

Conclusion: Strategic Insights for Future Growth

In summary, the botulinum toxins market continues to evolve as a dynamic intersection of medical innovation and aesthetic excellence. The comprehensive analysis presented herein highlights the intricate interplay between technological advancements, evolving regulatory landscapes, and a diverse array of customer needs. With a thorough understanding of segmentation across product types, forms, modes of administration, distribution channels, applications, and end-user profiles, stakeholders are better equipped to predict industry trends and identify lucrative opportunities. Regional dynamics further underscore the versatility of market drivers, while the competitive landscape reveals that continuous innovation and strategic partnerships are key to sustaining growth. As the market adapts to emerging challenges and shifts in consumer behavior, companies that invest in robust research, comprehensive market intelligence, and agile operational strategies will be best positioned to thrive. The insights provided serve as a roadmap for decision-makers aiming to shape the future of botulinum toxins, driving not only improved clinical outcomes and enhanced patient satisfaction but also broader industry success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing global demand for non-invasive cosmetic and aesthetic procedures
      • 5.1.1.2. Increasing awareness of aesthetic benefits among younger demographics
      • 5.1.1.3. Expanding therapeutic applications of botulinum toxins in healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulatory frameworks and safety concerns impacting market growth
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising global medical tourism driven by affordable aesthetic treatment costs
      • 5.1.3.2. Advancements in botulinum toxin formulations and innovative delivery technologies
    • 5.1.4. Challenges
      • 5.1.4.1. High costs of botulinum toxin treatments and limited reimbursement availability
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing adoption of Botulinum Toxin Type A owing to the efficacy in treating conditions
    • 5.2.2. Form: Rising preference for liquid form of botulinum toxins for quick and efficient administration
    • 5.2.3. Mode of Administration: Rising utilization of intradermal administration in dermatological and cosmetic procedures
    • 5.2.4. Distribution Channel: Rising consumer prefernce of offline retail for face-to-face consultations and instant assessments from skilled professionals
    • 5.2.5. Application: Expanding utilization of botulinum toxins for enhancement of facial contours
    • 5.2.6. End User: Growing usage of botulinum toxins in dermatology clinics for wrinkle reduction
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Botulinum Toxins Market, by Type

  • 6.1. Introduction
  • 6.2. Botulinum Toxin Type A
  • 6.3. Botulinum Toxin Type B

7. Botulinum Toxins Market, by Form

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Powder

8. Botulinum Toxins Market, by Mode of Administration

  • 8.1. Introduction
  • 8.2. Intradermal
  • 8.3. Intramuscular

9. Botulinum Toxins Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline Retail
  • 9.3. Online Retail

10. Botulinum Toxins Market, by Application

  • 10.1. Introduction
  • 10.2. Aesthetic Applications
    • 10.2.1. Facial Aesthetics
    • 10.2.2. Hyperhidrosis
    • 10.2.3. Non-Surgical Facelifts
  • 10.3. Medical Applications
    • 10.3.1. Gastrointestinal Disorders
    • 10.3.2. Muscle Spasms & Paralysis
    • 10.3.3. Pain Management

11. Botulinum Toxins Market, by End User

  • 11.1. Introduction
  • 11.2. Dermatology Clinics
  • 11.3. Hospitals & Clinics
  • 11.4. Medical Spas
  • 11.5. Research & Academic Institutes

12. Americas Botulinum Toxins Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Botulinum Toxins Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Botulinum Toxins Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Hugel receives UAE approval for botulinum toxin Botulax
    • 15.3.2. Hugel and Medica join forces to expand botulinum toxin distribution in Middle East, North Africa region
    • 15.3.3. Vensica Medical secured USD 11 million for needle-free botulinum toxin A delivery
    • 15.3.4. Allergan Aesthetics announced the FDA approval of BOTOX Cosmetic
    • 15.3.5. Allergan Aesthetics enhances treatment for masseter muscle prominence with BOTOX Cosmetic in China
    • 15.3.6. Galderma's Relfydess receives approval in Europe
    • 15.3.7. Merz Aesthetics secures FDA approval for XEOMIN as first U.S. neurotoxin for comprehensive upper facial line treatment
    • 15.3.8. Evolus expands global market reach with strategic launch of Nuceiva in Spain
    • 15.3.9. Letybo's FDA approval signals a new era in the US botulinum toxin market
    • 15.3.10. Collaboration between Curi Bio, Genetox, and DreamCIS enhances botulinum toxin assays
  • 15.4. Strategy Analysis & Recommendation
    • 15.4.1. Merz Pharma GmbH & Co. KGaA
    • 15.4.2. Hugel, Inc.
    • 15.4.3. Galderma SA
    • 15.4.4. AbbVie Inc.

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Ajinomoto Bio-Pharma Services
  • 3. ATGC Co.,Ltd.
  • 4. Bioplus Co., Ltd.
  • 5. Croma-Pharma GmbH
  • 6. Daewoong Pharmaceuticals Co.Ltd.
  • 7. Eirion Therapeutics, Inc.
  • 8. Eisai Co., Ltd
  • 9. Evolus, Inc.
  • 10. Galderma SA
  • 11. Gufic Biosciences Ltd.
  • 12. HUGEL, Inc.
  • 13. Hugh Source International Ltd.
  • 14. Ipsen Pharma
  • 15. Lanzhou Institute of Biological Products Co. Ltd.
  • 16. Medytox Co., Ltd.
  • 17. Merz Pharma GmbH & Co.KGaA
  • 18. Object Pharma, Inc.
  • 19. PharmaResearch Co. Ltd
  • 20. Revance Therapeutics, Inc.
  • 21. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • 22. Supernus Pharmaceuticals, Inc.
  • 23. Taj Pharmaceuticals

LIST OF FIGURES

  • FIGURE 1. BOTULINUM TOXINS MARKET MULTI-CURRENCY
  • FIGURE 2. BOTULINUM TOXINS MARKET MULTI-LANGUAGE
  • FIGURE 3. BOTULINUM TOXINS MARKET RESEARCH PROCESS
  • FIGURE 4. BOTULINUM TOXINS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BOTULINUM TOXINS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BOTULINUM TOXINS MARKET DYNAMICS
  • TABLE 7. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY BOTULINUM TOXIN TYPE A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY BOTULINUM TOXIN TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY FACIAL AESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY NON-SURGICAL FACELIFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY MUSCLE SPASMS & PARALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. THAILAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. THAILAND BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. THAILAND BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 199. DENMARK BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. DENMARK BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 201. DENMARK BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. EGYPT BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. EGYPT BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 209. EGYPT BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. FINLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. FINLAND BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 217. FINLAND BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. FRANCE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. FRANCE BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 225. FRANCE BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. GERMANY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. GERMANY BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. GERMANY BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 241. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. ITALY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. ITALY BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 249. ITALY BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 265. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. NORWAY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. NORWAY BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 273. NORWAY BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. POLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. POLAND BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 281. POLAND BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 282. POLAND BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. QATAR BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. QATAR BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 289. QATAR BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 290. QATAR BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 295. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 297. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 298. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 303. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 306. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 311. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 314. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. SPAIN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. SPAIN BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 321. SPAIN BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 322. SPAIN BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 327. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 329. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 330. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 335. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 337. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 338. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 343. TURKEY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. TURKEY BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 345. TURKEY BOTULINUM TOXINS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 346. TURKEY BOTULINUM TOXINS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY BOTULINUM TOXINS MARKET SIZE, BY MEDICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY BOTULINUM TOXINS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 351. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 352. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 353. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE,